1. Who we are

OrganoGEN Limited, a private company incorporated in the Republic of Cyprus, with registered office at Souliou 12, Mesa Geitonia, Limassol 4000, Cyprus. We are a GESY-registered medical-device distributor (supplier code ZC1093). For privacy, see our Privacy Policy, the Healthcare Professionals Privacy Policy, and the Medical-Device Vigilance Privacy Policy.

2. Acceptance of these Terms

By accessing or using organogenbiotech.com you agree to these Terms. If you do not agree, please do not use the site. We may update these Terms from time to time; the current revision date is shown at the bottom of the page. Material changes will be communicated through this page; we encourage you to review the Terms periodically.

3. Educational content and clinical disclaimer

All clinical content on this site (procedure guides, product specifications, condition explainers, FAQs, evidence summaries, and case studies) is for educational and informational purposes only. It is intended primarily for healthcare professionals and informed adult readers in Cyprus. It is not:

• medical advice, diagnosis, or treatment;
• a substitute for individual consultation with a qualified clinician;
• a recommendation that a specific procedure or device is appropriate for any specific patient;
• a guarantee of any clinical outcome.

Patient outcomes vary. Treatment decisions are made by a licensed clinician based on the individual circumstances of each patient. Where any content on this site addresses lay patients, it is intended to inform a conversation with a qualified surgeon, not to replace one. If you experience a medical emergency, call 112 (the EU emergency number) or your local emergency service.

4. Acceptable use

When using this site you agree not to:

• use the site for any unlawful purpose or in breach of applicable Cyprus or EU law;
• copy, reproduce, republish, or redistribute substantial portions of the site without prior written permission from OrganoGEN, except for personal, non-commercial reference;
• use scraping, crawling, or other automated means to harvest content for re-publication;
• misrepresent the source, accuracy, or completeness of OrganoGEN content;
• introduce viruses, malware, or other harmful code to the site or to OrganoGEN's systems;
• attempt to gain unauthorised access to any part of the site, OrganoGEN's networks, or related infrastructure;
• use the site to harass, defame, or distribute unsolicited communications.

OrganoGEN may suspend or limit access to the site (in whole or in part) if you breach these Terms, without prejudice to any other remedies available.

5. Intellectual property

All site content (including text, layout, design, graphics, logos, icons, image selection and arrangement, and code) is the property of OrganoGEN Limited or its content suppliers and is protected by Cypriot and international copyright, database, and trademark laws. Subject to section 4 you may view, download, and print pages from the site for personal, non-commercial reference only.

6. Trademarks

The following trademarks belong to the indicated owners and are used on this site under distribution arrangements:

• Touch®, KeriFlex®, and KeriFuse® are registered trademarks of KeriMedical SA.
• SmartBone® is a registered trademark of IBI SA.
• Vivostat® is a registered trademark of Vivostat A/S.
• Endoret® is a registered trademark of BTI Biotechnology Institute.
• Marrow Cellution™ is a trademark of Aspire Medical Innovation.
• Tulip® is a registered trademark of Tulip Medical Products.
• AUXILOCK® is a registered trademark of Auxein Medical.

All other trademarks, service marks, and trade names mentioned on the site are the property of their respective owners and are used for identification only. Their use on this site does not imply any endorsement, affiliation, or sponsorship beyond the OrganoGEN distribution arrangement.

7. Medical-device vigilance

If you have witnessed a serious incident or adverse event involving an OrganoGEN-distributed medical device, please contact OrganoGEN without delay at info@organogenbiotech.com. See the Medical-Device Vigilance Privacy Policy for how OrganoGEN handles such reports under EU Regulation 2017/745 (MDR) Article 87.

8. Regulatory framing

OrganoGEN distributes medical devices that are CE-marked under EU Regulation 2017/745 (Medical Device Regulation, MDR). Specific regulatory information (CE certificate references, Notified Body, manufacturer details) is available on each product page and on request. Statements on this site do not constitute regulatory advice or warranty; clinicians should refer to the manufacturer's Instructions for Use (IFU) for indications, contraindications, warnings, and full prescribing information.

9. External links

The site may link to third-party websites (for example, manufacturer pages, clinical-evidence databases like PubMed, regulatory authorities). OrganoGEN does not control these third-party sites and is not responsible for their content, accuracy, privacy practices, or availability. Inclusion of a link does not imply endorsement.

10. Disclaimer of warranties

The site is provided "as is" and "as available", to the fullest extent permitted by Cypriot law. OrganoGEN makes no warranties, express or implied, regarding the site or its content, including warranties of completeness, accuracy, currency, fitness for a particular purpose, or non-infringement. OrganoGEN does not warrant that the site will be uninterrupted, error-free, or free of viruses or other harmful components, although we take reasonable measures to that effect.

11. Limitation of liability

To the fullest extent permitted by Cypriot law, OrganoGEN Limited, its directors, officers, employees, and contractors shall not be liable for any indirect, incidental, consequential, special, exemplary, or punitive damages (including loss of profits, data, business, or goodwill) arising from or in connection with your use of the site or reliance on its content, even if OrganoGEN has been advised of the possibility of such damages. [Provisional: a specific monetary cap on OrganoGEN's aggregate liability will be inserted here in the final, counsel-reviewed version.]

Nothing in these Terms excludes or limits liability for fraud, gross negligence, or any other liability that cannot be lawfully excluded or limited under Cypriot or EU law.

12. Governing law and jurisdiction

These Terms are governed by the laws of the Republic of Cyprus. Any dispute arising from or in connection with these Terms or your use of the site shall be subject to the exclusive jurisdiction of the courts of the Republic of Cyprus, with the courts of Limassol as the competent venue. Nothing in this clause prevents OrganoGEN from seeking interim or injunctive relief in any other competent court.

13. Severability

If any provision of these Terms is found to be invalid or unenforceable by a competent court, the remaining provisions shall continue in full force, and the invalid or unenforceable provision shall be modified to the minimum extent necessary to make it valid and enforceable while preserving its original intent.

14. Status

This wording is provisional and will be reviewed by Cyprus-licensed legal counsel before final publication. Items marked [Provisional] in these Terms will be completed during the legal review.

15. Contact

OrganoGEN Limited · Souliou 12, Mesa Geitonia, Limassol 4000, Cyprus
Email: info@organogenbiotech.com

Last revision date: 2026-05-13. Version: 1.0 (provisional, pre-counsel-review).